Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
Medical Xpress on MSN
3D genome mapping tool reveals hidden complexity in DNA
Standard laboratory tests can fail to detect many disease-causing DNA changes. Now, a novel 3D chromosome mapping method can ...
Join Dwight Egan, CEO of Co-Dx, for an update on the Company's growth initiatives, including its recently announced definitive agreement with Arabian Eagle in the Kingdom of Saudi Arabia to form ...
Innovative cancer therapies are transforming treatment landscapes, yet access challenges persist. Experts discuss strategies ...
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
Antimicrobial resistance (AMR) represents one of the most pressing global health challenges of the 21st century, threatening the effectiveness of treatments and burdening healthcare systems worldwide.
The Chosun Ilbo on MSN
Chong Kun Dang Awards Kochon Prize to Molbio Diagnostics
The Chong Kun Dang Gochon Foundation announced that it has awarded the 18th Kochon Prize to Molbio Diagnostics, a molecular ...
A recording of this presentation will be made available on the company website. In addition, Biodesix executives, scientists, and expert consultants will be present at booth #647 to discuss Biodesix ...
Molbio Diagnostics receives the prestigious Kochon Prize for its innovative Truenat portable PCR system, transforming ...
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback